Global Inhalational Isoflurane Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Isoflurane is a widely used inhalational anesthetic agent employed in general anesthesia. It is a halogenated ether with the chemical formula C?H?ClF?O, and it functions by inducing a reversible loss of consciousness and sensation in patients undergoing surgical procedures. Isoflurane acts on the central nervous system by enhancing the inhibitory effects of neurotransmitters and disrupting neural pathways that mediate awareness and sensation. It is favored in clinical settings due to its stable cardiovascular effects, ease of control, and minimal metabolism by the liver. Its administration requires specialized equipment to ensure accurate delivery and maintenance of the desired anesthetic depth.
The global Inhalational Isoflurane market size is projected to grow from US$ 20.5 million in 2024 to US$ 26.5 million in 2030; it is expected to grow at a CAGR of 4.3% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Inhalational Isoflurane Industry Forecast” looks at past sales and reviews total world Inhalational Isoflurane sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhalational Isoflurane sales for 2024 through 2030. With Inhalational Isoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalational Isoflurane industry.
This Insight Report provides a comprehensive analysis of the global Inhalational Isoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalational Isoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalational Isoflurane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalational Isoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalational Isoflurane.
United States market for Inhalational Isoflurane is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Inhalational Isoflurane is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Inhalational Isoflurane is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Inhalational Isoflurane players cover KALBE PHARMA, Baxter, Neon Laboratories, AbbVie, Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalational Isoflurane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Inhalational Isoflurane market?
What factors are driving Inhalational Isoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalational Isoflurane market opportunities vary by end market size?
How does Inhalational Isoflurane break out by Type, by Application?
Isoflurane is a widely used inhalational anesthetic agent employed in general anesthesia. It is a halogenated ether with the chemical formula C?H?ClF?O, and it functions by inducing a reversible loss of consciousness and sensation in patients undergoing surgical procedures. Isoflurane acts on the central nervous system by enhancing the inhibitory effects of neurotransmitters and disrupting neural pathways that mediate awareness and sensation. It is favored in clinical settings due to its stable cardiovascular effects, ease of control, and minimal metabolism by the liver. Its administration requires specialized equipment to ensure accurate delivery and maintenance of the desired anesthetic depth.
The global Inhalational Isoflurane market size is projected to grow from US$ 20.5 million in 2024 to US$ 26.5 million in 2030; it is expected to grow at a CAGR of 4.3% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Inhalational Isoflurane Industry Forecast” looks at past sales and reviews total world Inhalational Isoflurane sales in 2023, providing a comprehensive analysis by region and market sector of projected Inhalational Isoflurane sales for 2024 through 2030. With Inhalational Isoflurane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Inhalational Isoflurane industry.
This Insight Report provides a comprehensive analysis of the global Inhalational Isoflurane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Inhalational Isoflurane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Inhalational Isoflurane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Inhalational Isoflurane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Inhalational Isoflurane.
United States market for Inhalational Isoflurane is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Inhalational Isoflurane is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Inhalational Isoflurane is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Inhalational Isoflurane players cover KALBE PHARMA, Baxter, Neon Laboratories, AbbVie, Piramal, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Inhalational Isoflurane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Generic Drugs
- Brand Drug
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- KALBE PHARMA
- Baxter
- Neon Laboratories
- AbbVie
- Piramal
- LAB UNKNOWN
- Viatris
- PT Novell Pharmaceutical
- Sedana Medical
- Lunan Beite
What is the 10-year outlook for the global Inhalational Isoflurane market?
What factors are driving Inhalational Isoflurane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Inhalational Isoflurane market opportunities vary by end market size?
How does Inhalational Isoflurane break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalational Isoflurane Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhalational Isoflurane by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhalational Isoflurane by Country/Region, 2019, 2023 & 2030
2.2 Inhalational Isoflurane Segment by Type
2.2.1 Generic Drugs
2.2.2 Brand Drug
2.3 Inhalational Isoflurane Sales by Type
2.3.1 Global Inhalational Isoflurane Sales Market Share by Type (2019-2024)
2.3.2 Global Inhalational Isoflurane Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhalational Isoflurane Sale Price by Type (2019-2024)
2.4 Inhalational Isoflurane Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Inhalational Isoflurane Sales by Application
2.5.1 Global Inhalational Isoflurane Sale Market Share by Application (2019-2024)
2.5.2 Global Inhalational Isoflurane Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhalational Isoflurane Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Inhalational Isoflurane Breakdown Data by Company
3.1.1 Global Inhalational Isoflurane Annual Sales by Company (2019-2024)
3.1.2 Global Inhalational Isoflurane Sales Market Share by Company (2019-2024)
3.2 Global Inhalational Isoflurane Annual Revenue by Company (2019-2024)
3.2.1 Global Inhalational Isoflurane Revenue by Company (2019-2024)
3.2.2 Global Inhalational Isoflurane Revenue Market Share by Company (2019-2024)
3.3 Global Inhalational Isoflurane Sale Price by Company
3.4 Key Manufacturers Inhalational Isoflurane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalational Isoflurane Product Location Distribution
3.4.2 Players Inhalational Isoflurane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INHALATIONAL ISOFLURANE BY GEOGRAPHIC REGION
4.1 World Historic Inhalational Isoflurane Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhalational Isoflurane Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhalational Isoflurane Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhalational Isoflurane Market Size by Country/Region (2019-2024)
4.2.1 Global Inhalational Isoflurane Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhalational Isoflurane Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalational Isoflurane Sales Growth
4.4 APAC Inhalational Isoflurane Sales Growth
4.5 Europe Inhalational Isoflurane Sales Growth
4.6 Middle East & Africa Inhalational Isoflurane Sales Growth
5 AMERICAS
5.1 Americas Inhalational Isoflurane Sales by Country
5.1.1 Americas Inhalational Isoflurane Sales by Country (2019-2024)
5.1.2 Americas Inhalational Isoflurane Revenue by Country (2019-2024)
5.2 Americas Inhalational Isoflurane Sales by Type (2019-2024)
5.3 Americas Inhalational Isoflurane Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalational Isoflurane Sales by Region
6.1.1 APAC Inhalational Isoflurane Sales by Region (2019-2024)
6.1.2 APAC Inhalational Isoflurane Revenue by Region (2019-2024)
6.2 APAC Inhalational Isoflurane Sales by Type (2019-2024)
6.3 APAC Inhalational Isoflurane Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhalational Isoflurane by Country
7.1.1 Europe Inhalational Isoflurane Sales by Country (2019-2024)
7.1.2 Europe Inhalational Isoflurane Revenue by Country (2019-2024)
7.2 Europe Inhalational Isoflurane Sales by Type (2019-2024)
7.3 Europe Inhalational Isoflurane Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalational Isoflurane by Country
8.1.1 Middle East & Africa Inhalational Isoflurane Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhalational Isoflurane Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhalational Isoflurane Sales by Type (2019-2024)
8.3 Middle East & Africa Inhalational Isoflurane Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalational Isoflurane
10.3 Manufacturing Process Analysis of Inhalational Isoflurane
10.4 Industry Chain Structure of Inhalational Isoflurane
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalational Isoflurane Distributors
11.3 Inhalational Isoflurane Customer
12 WORLD FORECAST REVIEW FOR INHALATIONAL ISOFLURANE BY GEOGRAPHIC REGION
12.1 Global Inhalational Isoflurane Market Size Forecast by Region
12.1.1 Global Inhalational Isoflurane Forecast by Region (2025-2030)
12.1.2 Global Inhalational Isoflurane Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Inhalational Isoflurane Forecast by Type (2025-2030)
12.7 Global Inhalational Isoflurane Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 KALBE PHARMA
13.1.1 KALBE PHARMA Company Information
13.1.2 KALBE PHARMA Inhalational Isoflurane Product Portfolios and Specifications
13.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 KALBE PHARMA Main Business Overview
13.1.5 KALBE PHARMA Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Inhalational Isoflurane Product Portfolios and Specifications
13.2.3 Baxter Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Neon Laboratories
13.3.1 Neon Laboratories Company Information
13.3.2 Neon Laboratories Inhalational Isoflurane Product Portfolios and Specifications
13.3.3 Neon Laboratories Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Neon Laboratories Main Business Overview
13.3.5 Neon Laboratories Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Inhalational Isoflurane Product Portfolios and Specifications
13.4.3 AbbVie Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Inhalational Isoflurane Product Portfolios and Specifications
13.5.3 Piramal Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 LAB UNKNOWN
13.6.1 LAB UNKNOWN Company Information
13.6.2 LAB UNKNOWN Inhalational Isoflurane Product Portfolios and Specifications
13.6.3 LAB UNKNOWN Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LAB UNKNOWN Main Business Overview
13.6.5 LAB UNKNOWN Latest Developments
13.7 Viatris
13.7.1 Viatris Company Information
13.7.2 Viatris Inhalational Isoflurane Product Portfolios and Specifications
13.7.3 Viatris Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Viatris Main Business Overview
13.7.5 Viatris Latest Developments
13.8 PT Novell Pharmaceutical
13.8.1 PT Novell Pharmaceutical Company Information
13.8.2 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolios and Specifications
13.8.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 PT Novell Pharmaceutical Main Business Overview
13.8.5 PT Novell Pharmaceutical Latest Developments
13.9 Sedana Medical
13.9.1 Sedana Medical Company Information
13.9.2 Sedana Medical Inhalational Isoflurane Product Portfolios and Specifications
13.9.3 Sedana Medical Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Sedana Medical Main Business Overview
13.9.5 Sedana Medical Latest Developments
13.10 Lunan Beite
13.10.1 Lunan Beite Company Information
13.10.2 Lunan Beite Inhalational Isoflurane Product Portfolios and Specifications
13.10.3 Lunan Beite Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Lunan Beite Main Business Overview
13.10.5 Lunan Beite Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. Inhalational Isoflurane Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Inhalational Isoflurane Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Brand Drug
Table 5. Global Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 6. Global Inhalational Isoflurane Sales Market Share byType (2019-2024)
Table 7. Global Inhalational Isoflurane Revenue byType (2019-2024) & ($ million)
Table 8. Global Inhalational Isoflurane Revenue Market Share byType (2019-2024)
Table 9. Global Inhalational Isoflurane Sale Price byType (2019-2024) & (US$/Unit)
Table 10. Global Inhalational Isoflurane Sale by Application (2019-2024) & (K Units)
Table 11. Global Inhalational Isoflurane Sale Market Share by Application (2019-2024)
Table 12. Global Inhalational Isoflurane Revenue by Application (2019-2024) & ($ million)
Table 13. Global Inhalational Isoflurane Revenue Market Share by Application (2019-2024)
Table 14. Global Inhalational Isoflurane Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Inhalational Isoflurane Sales by Company (2019-2024) & (K Units)
Table 16. Global Inhalational Isoflurane Sales Market Share by Company (2019-2024)
Table 17. Global Inhalational Isoflurane Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Inhalational Isoflurane Revenue Market Share by Company (2019-2024)
Table 19. Global Inhalational Isoflurane Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Inhalational Isoflurane Producing Area Distribution and Sales Area
Table 21. Players Inhalational Isoflurane Products Offered
Table 22. Inhalational Isoflurane Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Inhalational Isoflurane Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Inhalational Isoflurane Sales Market Share Geographic Region (2019-2024)
Table 27. Global Inhalational Isoflurane Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Inhalational Isoflurane Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Inhalational Isoflurane Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Inhalational Isoflurane Sales Market Share by Country/Region (2019-2024)
Table 31. Global Inhalational Isoflurane Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Inhalational Isoflurane Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)
Table 34. Americas Inhalational Isoflurane Sales Market Share by Country (2019-2024)
Table 35. Americas Inhalational Isoflurane Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 37. Americas Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 38. APAC Inhalational Isoflurane Sales by Region (2019-2024) & (K Units)
Table 39. APAC Inhalational Isoflurane Sales Market Share by Region (2019-2024)
Table 40. APAC Inhalational Isoflurane Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 42. APAC Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 43. Europe Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)
Table 44. Europe Inhalational Isoflurane Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 46. Europe Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Inhalational Isoflurane Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 50. Middle East & Africa Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Inhalational Isoflurane
Table 52. Key Market Challenges & Risks of Inhalational Isoflurane
Table 53. Key IndustryTrends of Inhalational Isoflurane
Table 54. Inhalational Isoflurane Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Inhalational Isoflurane Distributors List
Table 57. Inhalational Isoflurane Customer List
Table 58. Global Inhalational Isoflurane SalesForecast by Region (2025-2030) & (K Units)
Table 59. Global Inhalational Isoflurane RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Inhalational Isoflurane SalesForecast by Country (2025-2030) & (K Units)
Table 61. Americas Inhalational Isoflurane Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Inhalational Isoflurane SalesForecast by Region (2025-2030) & (K Units)
Table 63. APAC Inhalational Isoflurane Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Inhalational Isoflurane SalesForecast by Country (2025-2030) & (K Units)
Table 65. Europe Inhalational Isoflurane RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Inhalational Isoflurane SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Inhalational Isoflurane RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Inhalational Isoflurane SalesForecast byType (2025-2030) & (K Units)
Table 69. Global Inhalational Isoflurane RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Inhalational Isoflurane SalesForecast by Application (2025-2030) & (K Units)
Table 71. Global Inhalational Isoflurane RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. KALBE PHARMA Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 73. KALBE PHARMA Inhalational Isoflurane Product Portfolios and Specifications
Table 74. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. KALBE PHARMA Main Business
Table 76. KALBE PHARMA Latest Developments
Table 77. Baxter Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Inhalational Isoflurane Product Portfolios and Specifications
Table 79. Baxter Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Neon Laboratories Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 83. Neon Laboratories Inhalational Isoflurane Product Portfolios and Specifications
Table 84. Neon Laboratories Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Neon Laboratories Main Business
Table 86. Neon Laboratories Latest Developments
Table 87. AbbVie Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Inhalational Isoflurane Product Portfolios and Specifications
Table 89. AbbVie Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Inhalational Isoflurane Product Portfolios and Specifications
Table 94. Piramal Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. LAB UNKNOWN Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 98. LAB UNKNOWN Inhalational Isoflurane Product Portfolios and Specifications
Table 99. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. LAB UNKNOWN Main Business
Table 101. LAB UNKNOWN Latest Developments
Table 102. Viatris Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 103. Viatris Inhalational Isoflurane Product Portfolios and Specifications
Table 104. Viatris Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Viatris Main Business
Table 106. Viatris Latest Developments
Table 107. PT Novell Pharmaceutical Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 108. PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolios and Specifications
Table 109. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. PT Novell Pharmaceutical Main Business
Table 111. PT Novell Pharmaceutical Latest Developments
Table 112. Sedana Medical Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 113. Sedana Medical Inhalational Isoflurane Product Portfolios and Specifications
Table 114. Sedana Medical Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Sedana Medical Main Business
Table 116. Sedana Medical Latest Developments
Table 117. Lunan Beite Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 118. Lunan Beite Inhalational Isoflurane Product Portfolios and Specifications
Table 119. Lunan Beite Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Lunan Beite Main Business
Table 121. Lunan Beite Latest Developments
LIST OFFIGURES
.
Figure 1. Picture of Inhalational Isoflurane
Figure 2. Inhalational Isoflurane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalational Isoflurane Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Inhalational Isoflurane Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Inhalational Isoflurane Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Inhalational Isoflurane Sales Market Share by Country/Region (2023)
Figure 10. Inhalational Isoflurane Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Generic Drugs
Figure 12. Product Picture of Brand Drug
Figure 13. Global Inhalational Isoflurane Sales Market Share byType in 2023
Figure 14. Global Inhalational Isoflurane Revenue Market Share byType (2019-2024)
Figure 15. Inhalational Isoflurane Consumed in Hospital
Figure 16. Global Inhalational Isoflurane Market: Hospital (2019-2024) & (K Units)
Figure 17. Inhalational Isoflurane Consumed in Clinic
Figure 18. Global Inhalational Isoflurane Market: Clinic (2019-2024) & (K Units)
Figure 19. Inhalational Isoflurane Consumed in Other
Figure 20. Global Inhalational Isoflurane Market: Other (2019-2024) & (K Units)
Figure 21. Global Inhalational Isoflurane Sale Market Share by Application (2023)
Figure 22. Global Inhalational Isoflurane Revenue Market Share by Application in 2023
Figure 23. Inhalational Isoflurane Sales by Company in 2023 (K Units)
Figure 24. Global Inhalational Isoflurane Sales Market Share by Company in 2023
Figure 25. Inhalational Isoflurane Revenue by Company in 2023 ($ millions)
Figure 26. Global Inhalational Isoflurane Revenue Market Share by Company in 2023
Figure 27. Global Inhalational Isoflurane Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Inhalational Isoflurane Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 30. Americas Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 31. APAC Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 32. APAC Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 33. Europe Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 34. Europe Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 37. Americas Inhalational Isoflurane Sales Market Share by Country in 2023
Figure 38. Americas Inhalational Isoflurane Revenue Market Share by Country (2019-2024)
Figure 39. Americas Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 40. Americas Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 41. United States Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Inhalational Isoflurane Sales Market Share by Region in 2023
Figure 46. APAC Inhalational Isoflurane Revenue Market Share by Region (2019-2024)
Figure 47. APAC Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 48. APAC Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 49. China Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 53. India Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwan Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Inhalational Isoflurane Sales Market Share by Country in 2023
Figure 57. Europe Inhalational Isoflurane Revenue Market Share by Country (2019-2024)
Figure 58. Europe Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 59. Europe Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 60. Germany Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 61.France Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Inhalational Isoflurane Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 67. Middle East & Africa Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 68. Egypt Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 71.Turkey Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Inhalational Isoflurane in 2023
Figure 74. Manufacturing Process Analysis of Inhalational Isoflurane
Figure 75. Industry Chain Structure of Inhalational Isoflurane
Figure 76. Channels of Distribution
Figure 77. Global Inhalational Isoflurane Sales MarketForecast by Region (2025-2030)
Figure 78. Global Inhalational Isoflurane Revenue Market ShareForecast by Region (2025-2030)
Figure 79. Global Inhalational Isoflurane Sales Market ShareForecast byType (2025-2030)
Figure 80. Global Inhalational Isoflurane Revenue Market ShareForecast byType (2025-2030)
Figure 81. Global Inhalational Isoflurane Sales Market ShareForecast by Application (2025-2030)
Figure 82. Global Inhalational Isoflurane Revenue Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Inhalational Isoflurane Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Inhalational Isoflurane by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Inhalational Isoflurane by Country/Region, 2019, 2023 & 2030
2.2 Inhalational Isoflurane Segment by Type
2.2.1 Generic Drugs
2.2.2 Brand Drug
2.3 Inhalational Isoflurane Sales by Type
2.3.1 Global Inhalational Isoflurane Sales Market Share by Type (2019-2024)
2.3.2 Global Inhalational Isoflurane Revenue and Market Share by Type (2019-2024)
2.3.3 Global Inhalational Isoflurane Sale Price by Type (2019-2024)
2.4 Inhalational Isoflurane Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Inhalational Isoflurane Sales by Application
2.5.1 Global Inhalational Isoflurane Sale Market Share by Application (2019-2024)
2.5.2 Global Inhalational Isoflurane Revenue and Market Share by Application (2019-2024)
2.5.3 Global Inhalational Isoflurane Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Inhalational Isoflurane Breakdown Data by Company
3.1.1 Global Inhalational Isoflurane Annual Sales by Company (2019-2024)
3.1.2 Global Inhalational Isoflurane Sales Market Share by Company (2019-2024)
3.2 Global Inhalational Isoflurane Annual Revenue by Company (2019-2024)
3.2.1 Global Inhalational Isoflurane Revenue by Company (2019-2024)
3.2.2 Global Inhalational Isoflurane Revenue Market Share by Company (2019-2024)
3.3 Global Inhalational Isoflurane Sale Price by Company
3.4 Key Manufacturers Inhalational Isoflurane Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Inhalational Isoflurane Product Location Distribution
3.4.2 Players Inhalational Isoflurane Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INHALATIONAL ISOFLURANE BY GEOGRAPHIC REGION
4.1 World Historic Inhalational Isoflurane Market Size by Geographic Region (2019-2024)
4.1.1 Global Inhalational Isoflurane Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Inhalational Isoflurane Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Inhalational Isoflurane Market Size by Country/Region (2019-2024)
4.2.1 Global Inhalational Isoflurane Annual Sales by Country/Region (2019-2024)
4.2.2 Global Inhalational Isoflurane Annual Revenue by Country/Region (2019-2024)
4.3 Americas Inhalational Isoflurane Sales Growth
4.4 APAC Inhalational Isoflurane Sales Growth
4.5 Europe Inhalational Isoflurane Sales Growth
4.6 Middle East & Africa Inhalational Isoflurane Sales Growth
5 AMERICAS
5.1 Americas Inhalational Isoflurane Sales by Country
5.1.1 Americas Inhalational Isoflurane Sales by Country (2019-2024)
5.1.2 Americas Inhalational Isoflurane Revenue by Country (2019-2024)
5.2 Americas Inhalational Isoflurane Sales by Type (2019-2024)
5.3 Americas Inhalational Isoflurane Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Inhalational Isoflurane Sales by Region
6.1.1 APAC Inhalational Isoflurane Sales by Region (2019-2024)
6.1.2 APAC Inhalational Isoflurane Revenue by Region (2019-2024)
6.2 APAC Inhalational Isoflurane Sales by Type (2019-2024)
6.3 APAC Inhalational Isoflurane Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Inhalational Isoflurane by Country
7.1.1 Europe Inhalational Isoflurane Sales by Country (2019-2024)
7.1.2 Europe Inhalational Isoflurane Revenue by Country (2019-2024)
7.2 Europe Inhalational Isoflurane Sales by Type (2019-2024)
7.3 Europe Inhalational Isoflurane Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Inhalational Isoflurane by Country
8.1.1 Middle East & Africa Inhalational Isoflurane Sales by Country (2019-2024)
8.1.2 Middle East & Africa Inhalational Isoflurane Revenue by Country (2019-2024)
8.2 Middle East & Africa Inhalational Isoflurane Sales by Type (2019-2024)
8.3 Middle East & Africa Inhalational Isoflurane Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Inhalational Isoflurane
10.3 Manufacturing Process Analysis of Inhalational Isoflurane
10.4 Industry Chain Structure of Inhalational Isoflurane
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Inhalational Isoflurane Distributors
11.3 Inhalational Isoflurane Customer
12 WORLD FORECAST REVIEW FOR INHALATIONAL ISOFLURANE BY GEOGRAPHIC REGION
12.1 Global Inhalational Isoflurane Market Size Forecast by Region
12.1.1 Global Inhalational Isoflurane Forecast by Region (2025-2030)
12.1.2 Global Inhalational Isoflurane Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Inhalational Isoflurane Forecast by Type (2025-2030)
12.7 Global Inhalational Isoflurane Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 KALBE PHARMA
13.1.1 KALBE PHARMA Company Information
13.1.2 KALBE PHARMA Inhalational Isoflurane Product Portfolios and Specifications
13.1.3 KALBE PHARMA Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 KALBE PHARMA Main Business Overview
13.1.5 KALBE PHARMA Latest Developments
13.2 Baxter
13.2.1 Baxter Company Information
13.2.2 Baxter Inhalational Isoflurane Product Portfolios and Specifications
13.2.3 Baxter Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Baxter Main Business Overview
13.2.5 Baxter Latest Developments
13.3 Neon Laboratories
13.3.1 Neon Laboratories Company Information
13.3.2 Neon Laboratories Inhalational Isoflurane Product Portfolios and Specifications
13.3.3 Neon Laboratories Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Neon Laboratories Main Business Overview
13.3.5 Neon Laboratories Latest Developments
13.4 AbbVie
13.4.1 AbbVie Company Information
13.4.2 AbbVie Inhalational Isoflurane Product Portfolios and Specifications
13.4.3 AbbVie Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 AbbVie Main Business Overview
13.4.5 AbbVie Latest Developments
13.5 Piramal
13.5.1 Piramal Company Information
13.5.2 Piramal Inhalational Isoflurane Product Portfolios and Specifications
13.5.3 Piramal Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Piramal Main Business Overview
13.5.5 Piramal Latest Developments
13.6 LAB UNKNOWN
13.6.1 LAB UNKNOWN Company Information
13.6.2 LAB UNKNOWN Inhalational Isoflurane Product Portfolios and Specifications
13.6.3 LAB UNKNOWN Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LAB UNKNOWN Main Business Overview
13.6.5 LAB UNKNOWN Latest Developments
13.7 Viatris
13.7.1 Viatris Company Information
13.7.2 Viatris Inhalational Isoflurane Product Portfolios and Specifications
13.7.3 Viatris Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Viatris Main Business Overview
13.7.5 Viatris Latest Developments
13.8 PT Novell Pharmaceutical
13.8.1 PT Novell Pharmaceutical Company Information
13.8.2 PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolios and Specifications
13.8.3 PT Novell Pharmaceutical Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 PT Novell Pharmaceutical Main Business Overview
13.8.5 PT Novell Pharmaceutical Latest Developments
13.9 Sedana Medical
13.9.1 Sedana Medical Company Information
13.9.2 Sedana Medical Inhalational Isoflurane Product Portfolios and Specifications
13.9.3 Sedana Medical Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Sedana Medical Main Business Overview
13.9.5 Sedana Medical Latest Developments
13.10 Lunan Beite
13.10.1 Lunan Beite Company Information
13.10.2 Lunan Beite Inhalational Isoflurane Product Portfolios and Specifications
13.10.3 Lunan Beite Inhalational Isoflurane Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Lunan Beite Main Business Overview
13.10.5 Lunan Beite Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
.
Table 1. Inhalational Isoflurane Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Inhalational Isoflurane Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Generic Drugs
Table 4. Major Players of Brand Drug
Table 5. Global Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 6. Global Inhalational Isoflurane Sales Market Share byType (2019-2024)
Table 7. Global Inhalational Isoflurane Revenue byType (2019-2024) & ($ million)
Table 8. Global Inhalational Isoflurane Revenue Market Share byType (2019-2024)
Table 9. Global Inhalational Isoflurane Sale Price byType (2019-2024) & (US$/Unit)
Table 10. Global Inhalational Isoflurane Sale by Application (2019-2024) & (K Units)
Table 11. Global Inhalational Isoflurane Sale Market Share by Application (2019-2024)
Table 12. Global Inhalational Isoflurane Revenue by Application (2019-2024) & ($ million)
Table 13. Global Inhalational Isoflurane Revenue Market Share by Application (2019-2024)
Table 14. Global Inhalational Isoflurane Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Inhalational Isoflurane Sales by Company (2019-2024) & (K Units)
Table 16. Global Inhalational Isoflurane Sales Market Share by Company (2019-2024)
Table 17. Global Inhalational Isoflurane Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Inhalational Isoflurane Revenue Market Share by Company (2019-2024)
Table 19. Global Inhalational Isoflurane Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Inhalational Isoflurane Producing Area Distribution and Sales Area
Table 21. Players Inhalational Isoflurane Products Offered
Table 22. Inhalational Isoflurane Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Inhalational Isoflurane Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Inhalational Isoflurane Sales Market Share Geographic Region (2019-2024)
Table 27. Global Inhalational Isoflurane Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Inhalational Isoflurane Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Inhalational Isoflurane Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Inhalational Isoflurane Sales Market Share by Country/Region (2019-2024)
Table 31. Global Inhalational Isoflurane Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Inhalational Isoflurane Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)
Table 34. Americas Inhalational Isoflurane Sales Market Share by Country (2019-2024)
Table 35. Americas Inhalational Isoflurane Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 37. Americas Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 38. APAC Inhalational Isoflurane Sales by Region (2019-2024) & (K Units)
Table 39. APAC Inhalational Isoflurane Sales Market Share by Region (2019-2024)
Table 40. APAC Inhalational Isoflurane Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 42. APAC Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 43. Europe Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)
Table 44. Europe Inhalational Isoflurane Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 46. Europe Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Inhalational Isoflurane Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Inhalational Isoflurane Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Inhalational Isoflurane Sales byType (2019-2024) & (K Units)
Table 50. Middle East & Africa Inhalational Isoflurane Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Inhalational Isoflurane
Table 52. Key Market Challenges & Risks of Inhalational Isoflurane
Table 53. Key IndustryTrends of Inhalational Isoflurane
Table 54. Inhalational Isoflurane Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Inhalational Isoflurane Distributors List
Table 57. Inhalational Isoflurane Customer List
Table 58. Global Inhalational Isoflurane SalesForecast by Region (2025-2030) & (K Units)
Table 59. Global Inhalational Isoflurane RevenueForecast by Region (2025-2030) & ($ millions)
Table 60. Americas Inhalational Isoflurane SalesForecast by Country (2025-2030) & (K Units)
Table 61. Americas Inhalational Isoflurane Annual RevenueForecast by Country (2025-2030) & ($ millions)
Table 62. APAC Inhalational Isoflurane SalesForecast by Region (2025-2030) & (K Units)
Table 63. APAC Inhalational Isoflurane Annual RevenueForecast by Region (2025-2030) & ($ millions)
Table 64. Europe Inhalational Isoflurane SalesForecast by Country (2025-2030) & (K Units)
Table 65. Europe Inhalational Isoflurane RevenueForecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Inhalational Isoflurane SalesForecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Inhalational Isoflurane RevenueForecast by Country (2025-2030) & ($ millions)
Table 68. Global Inhalational Isoflurane SalesForecast byType (2025-2030) & (K Units)
Table 69. Global Inhalational Isoflurane RevenueForecast byType (2025-2030) & ($ millions)
Table 70. Global Inhalational Isoflurane SalesForecast by Application (2025-2030) & (K Units)
Table 71. Global Inhalational Isoflurane RevenueForecast by Application (2025-2030) & ($ millions)
Table 72. KALBE PHARMA Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 73. KALBE PHARMA Inhalational Isoflurane Product Portfolios and Specifications
Table 74. KALBE PHARMA Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. KALBE PHARMA Main Business
Table 76. KALBE PHARMA Latest Developments
Table 77. Baxter Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 78. Baxter Inhalational Isoflurane Product Portfolios and Specifications
Table 79. Baxter Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Baxter Main Business
Table 81. Baxter Latest Developments
Table 82. Neon Laboratories Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 83. Neon Laboratories Inhalational Isoflurane Product Portfolios and Specifications
Table 84. Neon Laboratories Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Neon Laboratories Main Business
Table 86. Neon Laboratories Latest Developments
Table 87. AbbVie Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 88. AbbVie Inhalational Isoflurane Product Portfolios and Specifications
Table 89. AbbVie Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AbbVie Main Business
Table 91. AbbVie Latest Developments
Table 92. Piramal Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 93. Piramal Inhalational Isoflurane Product Portfolios and Specifications
Table 94. Piramal Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Piramal Main Business
Table 96. Piramal Latest Developments
Table 97. LAB UNKNOWN Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 98. LAB UNKNOWN Inhalational Isoflurane Product Portfolios and Specifications
Table 99. LAB UNKNOWN Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. LAB UNKNOWN Main Business
Table 101. LAB UNKNOWN Latest Developments
Table 102. Viatris Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 103. Viatris Inhalational Isoflurane Product Portfolios and Specifications
Table 104. Viatris Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Viatris Main Business
Table 106. Viatris Latest Developments
Table 107. PT Novell Pharmaceutical Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 108. PT Novell Pharmaceutical Inhalational Isoflurane Product Portfolios and Specifications
Table 109. PT Novell Pharmaceutical Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. PT Novell Pharmaceutical Main Business
Table 111. PT Novell Pharmaceutical Latest Developments
Table 112. Sedana Medical Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 113. Sedana Medical Inhalational Isoflurane Product Portfolios and Specifications
Table 114. Sedana Medical Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Sedana Medical Main Business
Table 116. Sedana Medical Latest Developments
Table 117. Lunan Beite Basic Information, Inhalational Isoflurane Manufacturing Base, Sales Area and Its Competitors
Table 118. Lunan Beite Inhalational Isoflurane Product Portfolios and Specifications
Table 119. Lunan Beite Inhalational Isoflurane Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Lunan Beite Main Business
Table 121. Lunan Beite Latest Developments
LIST OFFIGURES
.
Figure 1. Picture of Inhalational Isoflurane
Figure 2. Inhalational Isoflurane Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Inhalational Isoflurane Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Inhalational Isoflurane Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Inhalational Isoflurane Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Inhalational Isoflurane Sales Market Share by Country/Region (2023)
Figure 10. Inhalational Isoflurane Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Generic Drugs
Figure 12. Product Picture of Brand Drug
Figure 13. Global Inhalational Isoflurane Sales Market Share byType in 2023
Figure 14. Global Inhalational Isoflurane Revenue Market Share byType (2019-2024)
Figure 15. Inhalational Isoflurane Consumed in Hospital
Figure 16. Global Inhalational Isoflurane Market: Hospital (2019-2024) & (K Units)
Figure 17. Inhalational Isoflurane Consumed in Clinic
Figure 18. Global Inhalational Isoflurane Market: Clinic (2019-2024) & (K Units)
Figure 19. Inhalational Isoflurane Consumed in Other
Figure 20. Global Inhalational Isoflurane Market: Other (2019-2024) & (K Units)
Figure 21. Global Inhalational Isoflurane Sale Market Share by Application (2023)
Figure 22. Global Inhalational Isoflurane Revenue Market Share by Application in 2023
Figure 23. Inhalational Isoflurane Sales by Company in 2023 (K Units)
Figure 24. Global Inhalational Isoflurane Sales Market Share by Company in 2023
Figure 25. Inhalational Isoflurane Revenue by Company in 2023 ($ millions)
Figure 26. Global Inhalational Isoflurane Revenue Market Share by Company in 2023
Figure 27. Global Inhalational Isoflurane Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Inhalational Isoflurane Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 30. Americas Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 31. APAC Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 32. APAC Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 33. Europe Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 34. Europe Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Inhalational Isoflurane Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Inhalational Isoflurane Revenue 2019-2024 ($ millions)
Figure 37. Americas Inhalational Isoflurane Sales Market Share by Country in 2023
Figure 38. Americas Inhalational Isoflurane Revenue Market Share by Country (2019-2024)
Figure 39. Americas Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 40. Americas Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 41. United States Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Inhalational Isoflurane Sales Market Share by Region in 2023
Figure 46. APAC Inhalational Isoflurane Revenue Market Share by Region (2019-2024)
Figure 47. APAC Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 48. APAC Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 49. China Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 53. India Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 55. ChinaTaiwan Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Inhalational Isoflurane Sales Market Share by Country in 2023
Figure 57. Europe Inhalational Isoflurane Revenue Market Share by Country (2019-2024)
Figure 58. Europe Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 59. Europe Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 60. Germany Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 61.France Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Inhalational Isoflurane Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Inhalational Isoflurane Sales Market Share byType (2019-2024)
Figure 67. Middle East & Africa Inhalational Isoflurane Sales Market Share by Application (2019-2024)
Figure 68. Egypt Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 71.Turkey Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Inhalational Isoflurane Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Inhalational Isoflurane in 2023
Figure 74. Manufacturing Process Analysis of Inhalational Isoflurane
Figure 75. Industry Chain Structure of Inhalational Isoflurane
Figure 76. Channels of Distribution
Figure 77. Global Inhalational Isoflurane Sales MarketForecast by Region (2025-2030)
Figure 78. Global Inhalational Isoflurane Revenue Market ShareForecast by Region (2025-2030)
Figure 79. Global Inhalational Isoflurane Sales Market ShareForecast byType (2025-2030)
Figure 80. Global Inhalational Isoflurane Revenue Market ShareForecast byType (2025-2030)
Figure 81. Global Inhalational Isoflurane Sales Market ShareForecast by Application (2025-2030)
Figure 82. Global Inhalational Isoflurane Revenue Market ShareForecast by Application (2025-2030)
